Chronic wounds have become one of the fastest-growing healthcare concerns worldwide. Conditions such as diabetes, vascular diseases, autoimmune disorders, pressure ulcers, and aging populations have significantly increased the number of patients suffering from wounds that fail to heal properly.

Healthcare experts estimate that billions of dollars are spent annually treating chronic wounds, making them one of the largest financial burdens on healthcare systems. Surgical wounds, diabetic foot ulcers, burns, and traumatic injuries require prolonged treatment, repeated dressing changes, and intensive clinical care.

Traditional wound management often focuses on protecting the wound rather than actively stimulating regeneration. As a result, healing is delayed, infection risks increase, and patients frequently experience pain during dressing replacement.

Sabalan Scaffold Engineering addresses these challenges through advanced regenerative wound dressing scaffolds developed using tissue engineering principles. Our bioengineered scaffold not only protects the wound but also promotes natural tissue repair by encouraging cell migration, proliferation, and extracellular matrix formation.

The scaffold’s three-dimensional architecture allows cells to infiltrate the wound site more effectively, overcoming one of the major limitations of conventional wound dressings. Additionally, the scaffold provides excellent moisture balance while preventing excessive bacterial growth, reducing the likelihood of infection.

For diabetic patients, where poor circulation often delays healing, our scaffold supports angiogenesis—the development of new blood vessels—which improves oxygen delivery and accelerates tissue repair.

As the global burden of chronic wounds continues to rise, regenerative medicine will play an increasingly important role in improving patient outcomes while reducing long-term healthcare costs.